The European Patent Office (EPO) has published patent application EP4574160A1, titled 'COMPOSITION COMPRISING BIFIDOBACTERIUM BREVE STRAIN FOR USE IN THE PREVENTION OF SKIN ALLERGIES'. This application, filed by Hipp & Co, details a specific composition involving a Bifidobacterium breve strain intended for the prevention of skin allergies. The publication date is March 18, 2026.

This is a patent publication, which grants intellectual property rights rather than imposing direct regulatory obligations. Companies in the pharmaceutical, food manufacturing, or healthcare sectors involved in developing or marketing products for allergy prevention or treatment may find this patent relevant for competitive analysis or potential licensing opportunities. No immediate compliance actions are required for regulated entities based on this publication.